<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-pharmaceuticals-13-00096">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Werdan</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Pilz</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bujdoso</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Fraunberger</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Neeser</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Schmieder</surname>
    <given-names>R.E.</given-names>
   </name>
   <name>
    <surname>Viell</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Marget</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Seewald</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Walger</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Score-based immunoglobulin G therapy of patients with sepsis: The SBITS study</article-title>
  <source>Crit. Care Med.</source>
  <year>2007</year>
  <volume>35</volume>
  <fpage>2693</fpage>
  <lpage>2701</lpage>
  <?supplied-pmid 18074471?>
  <pub-id pub-id-type="pmid">18074471</pub-id>
 </element-citation>
</ref>
